MedDataX Logo

Parents as Partners: Effectiveness of the Program in a Portuguese Sample

NCT06483841 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-07-03

No results posted yet for this study

Summary

This study aims to assess the effectiveness of the "Parents as Partners" program (also named "Supporting Father Involvement"; Cowan et al., 2009) in a sample of Portuguese couples going through the transition to parenthood, i.e., with one child up to the age of 3 years old. The program aims to strengthen the coparenting relationship and consists of 2-hour 8 weekly group sessions attended by couples. Using a mixed-method approach, the researchers will conduct a randomized clinical trial aiming to assess the effectiveness of the intervention on primary and secondary outcomes. Lastly, participants' perceptions of the intervention usefulness will be assessed by conducting interviews with couples who participated in the intervention group (Parents as Partners).

Conditions

  • Healthy

Interventions

BEHAVIORAL

Parents as Partners

The Parents as Partners program consists of 8 weekly group sessions attended by couples and was developed to strengthen the coparental relationship and promote paternal involvement. After consenting to their participation, couples will be randomly assigned to one of two conditions: intervention group or waitlist-control group. Participants will be assessed before and after the intervention on (co)parental, dyadic and work-family dimensions. Baseline (before intervention), post-test (2 months after baseline) and a follow-up assessment 6 months after the program will be performed. The intervention group will participate in the program, focusing on 5 family domains: Parents as Individuals; Parent-Child Relationships; Couple Relationship; Family of Origin Patterns; Stressors and Supports. Parents in the waitlist-control group will receive the intervention once their participation in the study is finished and if positive outcomes are found.

Sponsors & Collaborators

  • Foundation for Science and Technology, Portugal

    collaborator OTHER

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Carolina Garraio, MsC · PhD Candidate

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2025-05-31
Completion
2026-03-31

Countries

  • Portugal

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483841 on ClinicalTrials.gov